Immunisation Update for 2014

2014 Immunisation Schedule

A schedule update from PHARMAC has been issued for implementation by 01 July 2014.

The National Immunisation Register has been updated as a result of the 2014 schedule changes (see Below for a summary of these changes).
 

MyPractice Update

Changes have been made to MyPractice to support changes to the Immunisation schedules and NIR requirements as requested by the Ministry of Health.

Most of these changes will take effect once the 14.6 or later updates are installed

The vaccine groups will also be updated with the correct‚ vaccines for the 6 week, 3 months, 5 months, 15 months, 4 Year and 11 Year schedules except the PCV13 vaccine.

A change from the PCV10 to the PCV13 pneumococcal vaccine will require manual updating as this is dependent on when your PCV10 stocks are depleted and‚ replaced with the new PCV13 vaccines. Please call the helpdesk if assistance is required for this step.

 

Instructions for vaccinators

Apart from updating the vaccine group, no change in how vaccines are scheduled or recorded is required by users.

Routine Childhood vaccines

When the appropriate vaccine group is selected e.g. 3M, the appropriate new vaccines will be presented. Enter /update details as before .

New funded vaccines

Some vaccines will require the new indication of Standard to be selected (for eligible patients) in order to make a claim.

Vaccines to be sent to NIR

If vaccines need to be sent to the NIR the message status will default to Send

2014 Immunisation Schedule Change

On 1 July 2014 the following changes were made to the National Immunisation Schedule.

All children transfer to the new Schedule from 1 July 2014, although the date the new vaccines are available may be later than 1 July while existing vaccine stocks are used up. There are no changes to the ages of the routine immunisation events.

Key Changes to the National Immunisation Schedule from 1 July 2014

 Vaccine   Brand Name   Scheduled event  Route  New/Replaces
 1  Rotavirus vaccine (RV5)   RotaTeq  6  weeks, 3  & 5 months  Oral  New on schedule
 2  13-valent pneumococcal vaccine (PCV13)  Prevenar 13  6 weeks, 3,  5, & 15 months  IM  Replaces: 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix) event at 6 weeks,  3, 5 and 15 months
 3. DTaP-IPV (paediatric diphtheria, tetanus, acellular pertussis and polio vaccine)

  • may be administered to children aged under 10 years for catch-up immunisation
  • change from the previous recommendation of age 7 years
4.   Tdap (adult tetanus, diphtheria and acellular pertussis vaccine)

  • may be administered to children aged under 18 years for catch-up immunisation
  • funded from age 7 to under 18 years
5.  DTaP-IPV-Hep B/Hib has been confirmed as a catch-up option for children aged 5 to under 7 years. 
6.  Funded quadrivalent human papillomavirus vaccine (HPV4, Gardasil)

  • may now be administered to girls from age 9 years; however,
  • the usual Schedule remains at age 12 years for girls only
7. All vaccines on the Schedule are funded for revaccination following immunosuppression 
8.  Serology testing for babies of HBsAg-positive mothers:

  • will now occur at 9 months
  • this is a change from the previous 5 month serology testing
  • babies should be placed on a practice recall system to have their blood tested at 9 months of age, and
  • check infants  records  the 15-month immunisation event to ensure that testing has occurred.
 9. Women with rubella antibody levels of<10 IU/ml are considered to be non-immune to rubella. This is a change from the previous recommendation of <15 IU/ml.
 10.  The following vaccines have been funded for special groups (ie children and adults at high risk of some diseases due to other medical conditions):

  • hepatitis A
  • hepatitis B
  • human papillomavirus
  • meningococcal
  • pertussis (Tdap)
  • pneumonia
  • varicella.